Clinical Trial Update: Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pegylated interferon alfa-2a plus ribavirin for treating Hepatitis C in HIV-infected patients completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis C, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2011-06-15